ED
RXII

Exane Derivatives’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Exane Derivatives’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100,000
Closed -$151K – 522
2014
Q4 		$151K Buy
+100,000
New +$151K 0.02% 219